We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
Diagnostic and advisory services for Lyme disease.
The review of the safety of isotretinoin has concluded.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
Information to assist with the laboratory diagnosis of Lyme disease and requirements for sample submission.
Government outlines action to make UK a world leader in tackling ethnic and other biases in medical devices.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Information from the National Health Service on conditions, treatments, local services and healthy living
Guidance for primary care on taking samples for diagnosing and treating fungal skin and nail infections; for consultation and adaptation.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Midlands Region, Judge D Barlow and Mr Robert Chumley-Roberts MCIEH, J.P on 12 August 2020
Information on taking, submitting and processing samples which potentially contain monkeypox virus.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).